Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine Sulfonamides as Novel Potential Anticancer Agents: Apoptosis, Oxidative Stress, and Cell Cycle Analysis
-
Published:2023-05-09
Issue:10
Volume:24
Page:8504
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Bukowski Karol1ORCID, Marciniak Beata1ORCID, Kciuk Mateusz12ORCID, Mujwar Somdutt3ORCID, Mojzych Mariusz4, Kontek Renata1ORCID
Affiliation:
1. Department of Molecular Biotechnology and Genetics, University of Lodz, 90-237 Lodz, Poland 2. Doctoral School of Exact and Natural Sciences, University of Lodz, 90-237 Lodz, Poland 3. Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India 4. Department of Chemistry, Siedlce University of Natural Sciences and Humanities, 08-110 Siedlce, Poland
Abstract
The current study continues the evaluation of the anticancer potential of three de novo synthesized pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides—MM129, MM130, and MM131—against human cancer cells of HeLa, HCT 116, PC-3, and BxPC-3 lines. The pro-apoptotic activity of the investigated sulfonamides was shown by observations of changes in the mitochondrial transmembrane potential of the tested cells, externalization of phosphatidylserine on the cellular membrane surface, and cell morphology in microscopic imaging. The computational studies have shown that MM129 exhibited the lowest binding energy values when docked against CDK enzymes. In addition, the highest stability was shown for complexes formed between MM129 and CDK5/8 enzymes. All examined compounds induced cell cycle arrest in the G0/G1 phase in the BxPC-3 and PC-3 cells and simultaneously caused the accumulation of cells in the S phase in the HCT 116 cells. In addition, the increase in the subG1 fraction was observed in PC-3 and HeLa cells. The application of a fluorescent H2DCFDA probe revealed the high pro-oxidative properties of the tested triazine derivatives, especially MM131. In conclusion, the obtained results suggest that MM129, MM130, and MM131 exhibited strong pro-apoptotic properties towards investigated cells, mainly against the HeLa and HCT 116 cell lines, and high pro-oxidative potential as well. Moreover, it is suggested that the anticancer activity of the tested compounds may be associated with their ability to inhibit CDK enzymes activities.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference102 articles.
1. Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview;Lang;Anti Cancer Agents Med. Chem.,2020 2. Mukhtar, M., Bilal, M., Rahdar, A., Barani, M., Arshad, R., Behl, T., Brisc, C., Banica, F., and Bungau, S. (2020). Nanomaterials for Diagnosis and Treatment of Brain Cancer: Recent Updates. Chemosensors, 8. 3. Cancer Statistics for the Year 2020: An Overview;Ferlay;Int. J. Cancer,2021 4. Advances in Immune Checkpoint Inhibitor Combination Strategies for Microsatellite Stable Colorectal Cancer;Ros;Front. Oncol.,2023 5. Apoptosis Assays for Quantifying the Bioactivity of Anticancer Drug Products;Brunelle;Drug Resist. Updates,2010
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|